FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377424007: Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3762024014 Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3762025010 Fluorometholone 1 mg/mL and sulfacetamide sodium 100 mg/mL eye suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Is a Product containing fluorometholone in ocular dose form (medicinal product form) false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Fluorometholone ophthalmic preparation false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sulfacetamide (substance) false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Fluorometholone false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Is a Product containing sulfacetamide (medicinal product) false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Is a Product containing sulfacetamide in ophthalmic dosage form false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form Eye suspension true Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Is a Fluorometholone and sulfacetamide only product in ocular dose form true Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength numerator value un false Inferred relationship Some 2
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value un false Inferred relationship Some 2
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 2
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Sulfacetamide sodium true Inferred relationship Some 1
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 2
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength numerator value 10^2 false Inferred relationship Some 1
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value un false Inferred relationship Some 1
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Sulfacetamide sodium true Inferred relationship Some 1
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Fluorometholone true Inferred relationship Some 2
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Fluorometholone true Inferred relationship Some 2
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient deux false Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 1
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 1
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Plays role Antibacterial therapeutic role (role) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start